The latest from Velocity Clinical Research

Paul Evans Named a Featured Speaker of the Cornell University Biotech and Pharmaceutical Summit

June 7, 2023

Paul Evans, PhD, President and Chief Executive Officer of Velocity, has been named a featured speaker of the Biotech and Pharmaceutical Management Summit through Cornell University. The summit at Cornell Tech will enable participants to engage with industry leaders and Cornell faculty in small … Read more

Ride4DEI Promotes Stronger Clinical Trial Industry

May 17, 2023
Ride4DEI Promotes Stronger Clinical Trial Industry

CUMBERLAND, MD – It’s been smooth biking so far for the ACRP Ride4DEI team as they wrapped up day three yesterday (May 16) en route from Pittsburgh, PA to Washington, D.C. in an effort to raise money and awareness promoting diversity on all levels … Read more

Velocity Makes Third German Site Acquisition With InterMed

May 4, 2023
Velocity Makes Third German Site Acquisition

Wiesbaden is the second largest city in the Frankfurt Rhine Main region of Germany, with a population of more than 300,000 people. The city is known for its architecture and is one of the oldest spa towns in Europe, with 26 hot springs. It … Read more

Velocity Announces Three C-Suite Hires to Fuel Growth

May 2, 2023

Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical site organization, today announces it has made three C-suite hires, as the company continues to dramatically expand its clinical site and patient organization, bringing research opportunities to more people. Nick Campbell joins as Chief Commercial Officer, … Read more

Four Takeaways From Velocity’s Clinical Trial Participant Advisory Committee

April 19, 2023

To gain deeper insight into the perspectives of clinical trial participants, Velocity has built the Participant Advisory Committee (PAC). The PAC comprises diverse current and past clinical trial participants from across the country. The Velocity PAC convenes regularly to discuss issues and share ideas … Read more

Tyler Adam, MD, Coauthors NEJM Article With Results From Phase 3 Maternal RSV Vaccine Study

April 6, 2023

Tyler Adam, MD, Principal Investigator at Velocity Clinical Research in Hastings, NE, supported the promising MATISSE Phase 3 maternal RSV vaccine study — results of which have been published in the article, “Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants” … Read more

Case Study: Doubling the Average Participation Rate of Diverse Populations in Cognivue’s FOCUS Study

March 22, 2023

Neuroscience company Cognivue enrolled more than double the national average participation rate of diverse populations in its Further the Objective and Clinical Understanding of Cognivue Study (FOCUS) study. Velocity supported the study by enrolling the entirety of the study’s more than 1,500 subjects across … Read more

Velocity is Now a Society for Clinical Research Sites Global Impact Partner

March 16, 2023

Velocity Clinical Research is now a Society for Clinical Research Sites (SCRS) Global Impact Partnership (GIP). Paul Evans, PhD, President and CEO of Velocity, said the company is excited to leverage this partnership to further improve clinical research, both within Velocity and industry-wide. “The … Read more

8 Insights From 9,000+ Real Clinical Trial Participant Surveys

January 29, 2023

Clinical trials — especially high-volume trials — are primarily designed to collect quantitative data. Collecting and reviewing qualitative data and experiential feedback from trial participants is rarely prioritized. Before being acquired by Velocity Clinical Research, Meridian Clinical Research built an in-house surveying system to … Read more

Velocity Announces Three Leadership Hires in Europe

January 24, 2023

Velocity Clinical Research (“Velocity”), the largest integrated research site organisation globally, today announces it has strengthened its European senior executive team with three strategic hires, as the firm continues its expansion in the region. Évelyne Newton joins as Vice President of Business Development, Sandra … Read more

Clinical Trials: What You Need to Know for 2023

January 23, 2023
Clinical Trials What You Need to Know for 2023

1: Consolidation and scale of the market It is well known that fragmentation of the clinical sites business has been identified as a market opportunity by private equity firms. As a result of a PE capital injection, there has been increased merger and acquisition … Read more

Brandon Essink, MD, CPI, is Lead Author of Article Providing Update on Zika Virus Vaccine Development

January 20, 2023

Brandon Essink, MD, CPI, was the lead author of the article, “The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials”. Dr. Essink oversaw … Read more

Learn more about Velocity's capabilities

Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.

Join a remarkable team doing remarkable work

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.

Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Site Representative in Office

Quality. Continuity. Velocity.